Please join us for our 2nd webinar in the acute leukaemia treatment updates series.
This webinar will update on how AML is treated today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.
The webinar seeks to explain the different types of intensive and non-intensive treatments, who can have a particular therapy, how they work, their efficacy and side effects.
Dr Emmanouil Nikolousis Consultant Haematologist and Leukaemia Care Trustee will be joined by a clinical nurse specialist and an AML patient to explore topics together and answer your questions during the discussion.
Register here > bit.ly/AMLWebinarLC
